The Hong Research Group is composed of research staff scientists, postdocs, and students—graduate, PharmD, and undergraduate—with a variety of backgrounds in biology, chemistry, and engineering, working together in a highly interdisciplinary and collaborative environment. We value diversity in our group and welcome new members who will broaden our perspectives.
Since 2008, Dr. Hong has led a research group under the major research theme of biomimetic nanotechnology for cancer diagnosis and treatment. He has been inducted as a Fellow to the American Institute for Medical and Biological Engineering (AIMBE) in 2022 and awarded the 2012 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies and the 2012 UIC Researcher of the Year – Rising Star Award. To date, Dr. Hong’s research has culminated in more than 120 peer-reviewed articles that have a combined total number of citations of approximately 20,000 with an h-index of 49, 1 co-edited book, eight book chapters, and more than 22 issued or pending patents. He has given more than 180 invited talks worldwide and attended more than 200 conference proceedings.